跳至主要内容
临床试验/NL-OMON21202
NL-OMON21202已完成不适用

Prevention of Migraine in Adolescents.

uts/Ohra0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Candidates are migraine patients, aged 13 to 18 years, living in Rotterdam.

排除标准

  • Patients suffering from asthma, allergies and diabetes are excluded as well as patients who’ve been using propanolol and/or relaxation therapy as a treatment less then 6 months before the start of the trial.

研究者

发起方
uts/Ohra

相似试验

Prevention of Migraine in Adolescents. | 临床试验